Search - tctmd.com

Displaying 501 - 520 of 1502

Sort: Relevancy | Date

Presentation BRS 2015

My grand vision for a bioresorbable future

Presenter: Patrick W. Serruys

February 10, 2015

Presentation BRS 2015

Lesion preparation

Presenter: Antonio Colombo

February 10, 2015

Presentation BRS 2015

Emerging clinical evidence I: Summarizing the registries

Presenter: Corrado Tamburino

February 10, 2015

Presentation BRS 2015

Diffuse Disease: Scaffold Overlap and Other Considerations

Presenter: Stephan Achenbach

February 10, 2015

Presentation BRS 2015

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Presenter: Antonio L. Bartorelli

February 10, 2015

Presentation BRS 2015

Are BRS Ideally Suited for CTO’s?Theory and Practical Recommendations

Presenter: Antonio Serra

February 10, 2015

Presentation BRS 2015

Are BRS Ideally Suited for ACS Lesions ?Theory and Practical Recommendations

Presenter: Dariusz Dudek

February 10, 2015

Presentation BRS 2015

A BRS complication

Presenter: Antonio Colombo

February 10, 2015

Presentation

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

Presenter: G.Tepe

February 04, 2015

Presentation ISET 2015

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

Presenter: Thomas Zeller

February 03, 2015

Presentation ISET 2015

New Insights from the IN.PACT SFA Randomized Trial

Presenter: Gunnar Tepe

February 02, 2015

Presentation ISET 2015

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Presenter: Gunnar Tepe

February 02, 2015

Presentation ISET 2015

Results of Approved DCB in the United States

Presenter: Gary M. Ansel

February 01, 2015

Presentation ISET 2015

Benefits of DCB in SFA Disease

Presenter: Thomas Zeller

February 01, 2015

Presentation ISET 2015

Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials?

Presenter: Michael R. Jaff

January 31, 2015

Presentation ISET 2015

Retrievable Stents: Technique and Results

Presenter: Italo Linfante

January 30, 2015

Presentation ISET 2015

Endovascular Therapy in the Management of Hypertension

Presenter: Barry T. Katzen

January 30, 2015

Presentation

Interoperator and Intraoperator (In)Accuracy of Stent Selection Based on Visual Estimation

Presenter: P.T. Campbell

January 28, 2015

Presentation

XAMI: Long-term Follow-up of Second-Generation DES vs First-Generation SES in AMI

Presenter: Sjoerd H. Hofma

January 26, 2015

Presentation

TE-PROVE: 1-year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium PES

Presenter: C. Tamburino

January 14, 2015

Advertisement

My grand vision for a bioresorbable future

Lesion preparation

Emerging clinical evidence I: Summarizing the registries

Diffuse Disease: Scaffold Overlap and Other Considerations

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Are BRS Ideally Suited for CTO’s?Theory and Practical Recommendations

Are BRS Ideally Suited for ACS Lesions ?Theory and Practical Recommendations

A BRS complication

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

New Insights from the IN.PACT SFA Randomized Trial

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Results of Approved DCB in the United States

Benefits of DCB in SFA Disease

Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials?

Retrievable Stents: Technique and Results

Endovascular Therapy in the Management of Hypertension

Interoperator and Intraoperator (In)Accuracy of Stent Selection Based on Visual Estimation

XAMI: Long-term Follow-up of Second-Generation DES vs First-Generation SES in AMI

TE-PROVE: 1-year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium PES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content